ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01083316
Brief Title: Bortezomib and Dexamethasone Followed by High-Dose Melphalan and Stem Cell Transplantation for Primary (AL) Amyloidosis

First Submitted : November 2, 2009
First Submitted that Met QC Criteria : March 8, 2010
First Posted : March 9, 2010 (Estimate)

Results First Submitted : December 13, 2016
Results First Submitted that Met QC Criteria : December 13, 2016
Results First Posted : February 6, 2017 (Estimate)

Last Update Submitted that Met QC Criteria : April 9, 2018
Last Update Posted : May 8, 2018